Published in J Urol on January 09, 2013
Novel Strategies in the Prevention and Treatment of Urinary Tract Infections. Pathogens (2016) 0.83
Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan. PLoS One (2013) 0.83
LL-37 induced cystitis and the receptor for advanced glycation end-products (RAGE) pathway. Adv Biosci Biotechnol (2013) 0.81
Topical cathelicidin (LL-37) an innate immune peptide induces acute olfactory epithelium inflammation in a mouse model. Int Forum Allergy Rhinol (2015) 0.76
Editorial comment. J Urol (2013) 0.75
Bladder pain in an LL-37 interstitial cystitis and painful bladder syndrome model. Am J Clin Exp Urol (2017) 0.75
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med (2006) 5.20
Mast cells in the development of adaptive immune responses. Nat Immunol (2005) 4.96
New concepts about the mast cell. N Engl J Med (1993) 3.43
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem (1998) 2.91
Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. J Urol (2005) 2.25
A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology (2002) 1.93
The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr Opin Hematol (2009) 1.92
Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol (2001) 1.73
Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome. Urology (2012) 1.71
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology (2007) 1.67
Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology (2001) 1.59
Mast cell-derived histamine mediates cystitis pain. PLoS One (2008) 1.40
Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol (2002) 1.25
Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism. Am J Physiol Renal Physiol (2002) 1.08
Mast cells mediate the severity of experimental cystitis in mice. J Urol (1999) 1.07
Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol (2002) 1.06
Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol (1983) 1.06
Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol (1997) 1.03
Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol (2000) 1.02
LPS-sensory peptide communication in experimental cystitis. Am J Physiol Renal Physiol (2002) 1.01
YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology (2010) 0.94
A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides. J Urol (2011) 0.94
Importance of TNF-related apoptosis-inducing ligand in pathogenesis of interstitial cystitis. Int Urol Nephrol (2009) 0.92
Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea. PLoS One (2011) 0.90
Summation model of pelvic pain in interstitial cystitis. Nat Clin Pract Urol (2008) 0.89
Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients. World J Urol (2007) 0.88
Altered expression of bladder mast cell growth factor receptor (c-kit) in interstitial cystitis. Urology (1998) 0.85
Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis. BJU Int (2008) 0.85
Mast cell chymase is a possible mediator of neurogenic bladder fibrosis. Neurourol Urodyn (2004) 0.84